NIH’s NIAID initiating dose evaluation studies in animal models of Pluristem’s PLX-R18 in the treatment of acute radiation syndrome

Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapy products, has announced that the National Institute of Allergy and Infectious Diseases (NIAID), a part of the U.S. Aid / Disasters News From Medical News Today BEST DEAL UPDATE: SPECIAL … Read more…

Thanks, Santa – A Cold Dose of Reality for the Holidays | The Daily Show

The Daily Show with Trevor Noah SPECIAL NEWS BULLETIN: http://www.acrx.org -As millions of Americans strive to deal with the economic downturn,loss of jobs,foreclosures,high cost of gas,and the rising cost of prescription drug cost. Charles Myrick ,the President of American Consultants … Read more…